Matthew is a Principal Scientist in the Preformulation Group at Merck & Co., Inc. where he supports drug product formulation development via physical characterization techniques including X-ray diffraction, thermal analysis, vibrational spectroscopy, and electron microscopy. He leads efforts within the group to identify and develop advanced characterization tools needed to support increasingly complex formulation strategies utilized in current pharmaceutical development. He is particularly enthusiastic about atomic force microscopy and continues to champion its application to drug development within Merck and the pharma industry at large. Prior to joining Schering-Plough/Merck, Matthew earned his PhD in materials science and engineering from the University of Delaware where his research focused on understanding structure-property relationships in self-assembling peptide and polymer systems for biomaterials applications. Matthew earned his BS in materials science and engineering from Virginia Tech where his undergraduate research involved mechanical testing of polymer-copolymer blends.